Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals

Martin NK, Vickerman P, Grebely J, et al. Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology. 2013;58(5):1598-1609.

Publication Type:

Journal Article

Authors:

N K Martin; Vickerman, P.; Grebely, J.; et, al

Source:

Hepatology, Volume 58, Issue 5, p.1598-1609 (2013)

Keywords:

Antiviral Agents, Australia, Budgets, Canada, chronic HCV, complications, Drug Costs, epidemiology, Harm Reduction, HCV, Health, hepatitis, Hepatitis C, hepatitis C virus, Humans, Hygiene, interventions, London, Medicine, Models,Theoretical, Prevalence, prevention, prevention & control, Research, Research Support, Risk, Substance Abuse,Intravenous, therapeutic use, therapy, transmission, treatment, Tropical Medicine

Notes:

PMC3933734

Cited On:

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/23553643

Export Citation:

RIS Format

Top